Trials / Completed
CompletedNCT01667055
The Diagnosis of Beta-lactam Hypersensitivity in Thailand
The Optimized Diagnostic Methods for the Confirmation of Beta-lactam Hypersensitivity in Thailand
- Status
- Completed
- Phase
- —
- Study type
- Observational
- Enrollment
- 500 (actual)
- Sponsor
- Chulalongkorn University · Academic / Other
- Sex
- All
- Age
- 7 Years
- Healthy volunteers
- Not accepted
Summary
The true prevalence of drug allergy in patients with a history of beta-lactam hypersensitivity will be determined by using commercially available standard skin test reagents and the diagnostic agents available in Thailand. We hypothesize that only minority of patients with such a history are truly allergic.
Detailed description
Patients with a history of beta-lactam hypersensitivity will be evaluated by the standard skin test reagents (major and minor determinants of penicillin, amoxicillin, and clavulanic if applicable), and intravenous forms of beta-lactam antibiotics . Diagnostic values of the measurement of specific Immunoglobulin E to penicillin/aminopenicillin and skin test reagents currently available in Thailand will be comparatively analyzed with the standard skin test reagents. The measurement of drug-induced interferon-gamma releasing cells will be measured in patients with a history of non-immediate reaction.
Conditions
Timeline
- Start date
- 2012-06-01
- Primary completion
- 2018-12-01
- Completion
- 2018-12-01
- First posted
- 2012-08-17
- Last updated
- 2019-10-29
Locations
1 site across 1 country: Thailand
Source: ClinicalTrials.gov record NCT01667055. Inclusion in this directory is not an endorsement.